[1] |
Xu Fenglin, Wu Gang.Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2024, 51(6): 359-363. |
[2] |
Gu Anqin, Long Jinhua, Jin Feng.Clinical research progress of immunotherapy for nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(5): 299-303. |
[3] |
Li Jinzhi, Zhao Biao, Wen Xiaobo, Zhang Ming, Yuan Meifang, Sun Mengzhen, Pu Qin, Yang Yi.The effects of different dose calculation grid size by Monaco planning system on the dosimetry of T4nasopharyngeal carcinoma[J]. Journal of International Oncology, 2023, 50(11): 641-649. |
[4] |
Chen Fangming, Cai Yuanyuan, Li Han, Wang Xiaoli, Kan Hongxing, Li Yang, Hao Furong, Wang Mingchen.Prognostic differences of nasopharyngeal carcinoma patients treated with intensity-modulated radiothe-rapy with different T staging of the seventh and eighth edition of the UICC staging system[J]. Journal of International Oncology, 2021, 48(9): 515-522. |
[5] |
Peng Ya, Liu An, Liu Huowang.Inhibitory effect and mechanism of PSD-007 photodynamic therapy on human nasopharyngeal carcinoma transplanted tumors in nude mice[J]. Journal of International Oncology, 2021, 48(3): 136-142. |
[6] |
Zhu Lei, Huang Jianbo.Effects of Epstein-Barr virus DNA load and different treatment methods on the therapeutic effect and prognosis of stage Ⅲ nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(2): 74-79. |
[7] |
Luo Wenxiao, Wu Dehua, Cai Longmei.Prognostic values of immune efficacy biomarkers in the treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2021, 48(12): 743-746. |
[8] |
Yang Minghui, Jin Feng.Value of 3D-ASL, MRS and DTI in the diagnosis and treatment of radiation-induced temporal lobe injury of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2020, 47(9): 550-554. |
[9] |
Yang Chao, Wang Jianbo, Zhang Juhong, Wang Jialong.Overexpression of miR-125 inhibits proliferation and invasion of nasopharyngeal carcinoma cells by down-regulating FGF-2[J]. Journal of International Oncology, 2020, 47(5): 257-263. |
[10] |
Shen Jianjun.Treatment of local recurrenct nasopharyngeal carcinoma after radiotherapy[J]. Journal of International Oncology, 2020, 47(4): 227-230. |
[11] |
Zhou Yuanyuan, Li Jing.Clinical practice value of hematological inflammation biomarkers in nasopharyngeal carcinoma[J]. Journal of International Oncology, 2019, 46(8): 492-495. |
[12] |
Zhou Ping, Chen Weisi, Zhang Shuang, Lin Bing, Pan Tao, Liu Sha.Observation of efficacy of paclitaxel with concurrent radiotherapy in the treatment for nasopharyngeal carcinoma patients with liver metastasis[J]. Journal of International Oncology, 2019, 46(6): 327-330. |
[13] |
CHEN Jiong-Yu, ZHUANG Yi-Xuan, ZHUANG Shan-Shan, PENG Lin.Effects of osthole on the proliferation, invasion and migration of nasopharyngeal carcinoma cells CNE2[J]. Journal of International Oncology, 2018, 45(8): 453-459. |
[14] |
LAI Shi-Jia, ZHAO De-An, SUN Yong-Ming.Expression and clinical significance of serum microRNA663 in nasopharyngeal carcinoma patients[J]. Journal of International Oncology, 2018, 45(8): 460-464. |
[15] |
Huang Ting, Song Xuewei, An Shufen, Wang Zhibin, Liao Hehe.Expressions of MDR-1 and P-gp in human nasopharyngeal squamous cell carcinoma CNE1 cell line after X-ray exposure[J]. Journal of International Oncology, 2018, 45(6): 321-324. |